These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 5150076

  • 1. Early coronary atherosclerosis in primary type V hyperlipoproteinemia.
    Steiner G, Adelman AG, Silver MD.
    Can Med Assoc J; 1971 Dec 04; 105(11):1172-4. PubMed ID: 5150076
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Arteriosclerosis and plasma lipoprotein--lipoprotein abnormalities and sclerotic cardiovascular diseases in patients with mental disorders].
    Wada M, Tsuji H, Minamizono T, Komoda M, Nakaoka H.
    Saishin Igaku; 1970 Oct 04; 25(10):2197-207. PubMed ID: 5482573
    [No Abstract] [Full Text] [Related]

  • 4. [Lipoprotein lipase and post-heparin esterase activity in primary type IV and V hyperlipoproteinemia].
    Kucerová L, Fabian E, Fabianová J.
    Cas Lek Cesk; 1974 Apr 26; 113(17):519-22. PubMed ID: 4451922
    [No Abstract] [Full Text] [Related]

  • 5. [The clinical significance of the risk factor hyperlipoproteinemia. Study on 2700 patients].
    Dabels J, Rinke E.
    Z Gesamte Inn Med; 1977 Jul 01; 32(13):194-6. PubMed ID: 930179
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical study on the relationship between diabetes, hyperlipoproteinemia and atheromatosis].
    Righetti A, Scherrer JR, Micheli H, Pometta D.
    Schweiz Med Wochenschr; 1973 May 05; 103(18):668-73. PubMed ID: 4702987
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Arteriosclerosis in primary hyperlipoproteinemia].
    Kucerová L, Voslárová Z, Papezová R.
    Sb Lek; 1973 Jun 05; 75(6):161-8. PubMed ID: 4709455
    [No Abstract] [Full Text] [Related]

  • 11. [Hyperlipoproteinemia (Frederickson's classification) in patients with myocardial infarction and imminent infarction].
    Kedra M, Poleszak J, Rymar B.
    Pol Tyg Lek; 1975 Jun 02; 30(22):945-7. PubMed ID: 1135069
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lipoproteins and atherosclerosis in children: an early marriage?
    Strong JP, Zieske AW, Malcom GT.
    Nutr Metab Cardiovasc Dis; 2001 Oct 02; 11 Suppl 5():16-22. PubMed ID: 12063771
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rationale for use of lipid-lowering drugs.
    Dayton S.
    Fed Proc; 1971 Oct 02; 30(3):849-56. PubMed ID: 5575297
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Incidence of hyperlipoproteinemia in patients with past myocardial infarct].
    Ciświcka-Sznajderman M, Mlyński J, Lotholc J.
    Pol Tyg Lek; 1972 Oct 23; 27(43):1673-6. PubMed ID: 4639620
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.